The Australian Podiatry Association (APodA) is calling on the Australian Senate to support a simple yet important amendment to the Health Legislation Amendment (Prescribing of Pharmaceutical Benefits) Bill 2025, so that patients treated by podiatrists with prescribing endorsements can access Pharmaceutical Benefits Scheme (PBS) subsidies. Read on to learn more about our work to improve outcomes for podiatrists and patients.

APodA’s February advocacy update highlights key progress across PBS parity, primary care reform, NDIS consultations and aged care changes. Explore current submissions, member driven insights and practical resources supporting your practice. Stay informed and connected to the national advocacy shaping the future of podiatry.

We were thrilled to partner with the Australasian College of Podiatric Surgeons (ACPS) to bring two valuable learning experiences to podiatrists across Australia in 2025. Learn more about this important collaboration to support podiatrists with high-quality education and training that ultimately benefits patient care across Australia.

The NDIS has launched its Annual Price Review for 2025–2026, which includes therapy supports such as podiatry. This is a chance for the podiatry community to raise their voice on this important area of pricing of podiatry services. Learn more about NDIS Annual Pricing Review consultations.

A new Chronic Wound Consumables Scheme (CWCS) is coming soon, covering the cost of wound consumable products such as bandages, dressings and adhesives for people aged 65 and over or First Nations people aged 50 and over with diabetes and a chronic wound.